Clinical Trial Update: Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke [NA]

View source ↗

Summary

A trial is planned to assess the efficacy and safety of combining human urinary kallidinogenase with reteplase intravenous thrombolysis for acute ischemic strok…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Human Urinary Kallidinogenase (kallidinogenase)
• Reteplase (reteplase)

Snippet

Sponsor: China-Japan Union Hospital | Conditions: Acute Ischemic Stroke | NA | Status: NOT_YET_RECRUITING